Inactive Instrument

Other languages Heron Therapeutics Inc OTC Bulletin Board

Equities

APPAD

US4277461020

Other languages

Unlock all the news: Be the first to know and act before the market!

Heron Therapeutics Says Non-Opioid Pain Medication to be Included in Proposed Medicare Programs	Jul. 15
Heron Therapeutics, Inc. Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System	Jul. 15
Heron Reports Acceptance of Prior Approval Supplement Application for Zynrelef Vial Access Needle	Jul. 02
Heron Therapeutics, Inc. Announces Acceptance of the Prior Approval Supplement Application for Zynrelef® Vial Access Needle	Jul. 02
Connect Biopharma Names New Chief Executive, Chair	Jun. 12
Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle	May. 29
Heron Therapeutics, Inc. Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")	May. 29
Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07
Heron Therapeutics, Inc. Re-Affirms Earnings Guidance for the Full Year 2024	May. 07
Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024	Mar. 21
Sector Update: Health Care Stocks Slipping Late Afternoon	Mar. 13
Heron Therapeutics Shares Soar After Q4 Results Beat	Mar. 13
Heron Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12
Heron Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 12
Heron Therapeutics, Inc. Re-Affirms Earnings Guidance for the Full Year 2024	Mar. 12
Heron Therapeutics Says FDA Approved Expanded Label for Zynrelef to Add More Orthopedic, Soft Tissue Procedures	Jan. 24
Heron Therapeutics, Inc. Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures	Jan. 23
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday Amid Boeing 737 Max 9 Grounding	Jan. 08
Heron Therapeutics Unveils Deal to Expand Sales Network for Postoperative Pain Control Anesthetic; Shares Rise Premarket	Jan. 08
Heron Therapeutics, Inc. Enters into Five-Year Distributor Partnership with Crosslink Life Sciences, LLC to Expand the Sales Network Supporting ZYNRELEF	Jan. 07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Heron Therapeutics Inc OTC Bulletin Board

Equities

APPAD

US4277461020

Other languages

Filters